Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for DBVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
March 31, 2026 207.90M
December 31, 2025 168.77M
September 30, 2025 52.85M
June 30, 2025 86.22M
March 31, 2025 2.873M
December 31, 2024 27.39M
September 30, 2024 54.03M
June 30, 2024 79.10M
March 31, 2024 111.65M
December 31, 2023 140.19M
September 30, 2023 143.99M
Date Value
June 30, 2023 164.24M
March 31, 2023 179.09M
December 31, 2022 194.45M
September 30, 2022 212.05M
June 30, 2022 244.42M
March 31, 2022 82.06M
December 31, 2021 99.03M
September 30, 2021 116.89M
June 30, 2021 143.02M
March 31, 2021 169.18M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Cellectis SA 41.07M
Akari Therapeutics Plc 18.60M
EDAP TMS SA -3.225M
Autolus Therapeutics Plc 74.84M
Evaxion AS 9.531M

Shareholders Equity (Quarterly) Related Metrics